Trade Summary

3 days ago, Krop Julie, serving as Dir at Aquestive Therapeutics, Inc. (AQST), sold 25,000 shares at $5.02 per share, for a total transaction value of $125,392.50.

This sale represents a 100.00% decrease in Krop Julie's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 24, 2026 at 11:11 AM ET, 1 day after the trade was made.

Aquestive Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.